All News
Telemedicine Studies: A Trainee’s Perspective
The shift from face-to-face consultations to telemedicine has been immense for clinicians and patients. Given the numerous challenges and nuances in practising telemedicine, it is apt that ACR 2020 has been packed with abstracts and presentations on this topic.
Read Article
Abst#L01. Pt is on MTX/ADA for RA and asks you about their COVID risk. What do you counsel your patient? #ACR20 @RheumNow.
Eric Dein ejdein1 ( View Tweet)
What are you telling rheum pts their risk is for COVID? MGH: higher unadjusted rate of mech ventilation, but not signif difference after adj for co-morbidities. Encouraging temporal improvement in care seen. Abst#L01 #ACR20 @Rheumnow https://t.co/BnPCtbo5Nj
Eric Dein ejdein1 ( View Tweet)
Poster #L02 by @yatesmark1 et al shows #shielding in #IMID population on biologics may at least in part explain the lower risk of adverse #COVID19 outcomes in this group. Reinforces need for clear guidance on risk mitigation for patients.
#ACR20 @RheumNow
https://t.co/H4RMbfBrH2
Mrinalini Dey DrMiniDey ( View Tweet)
Fatigue in RA - massive burden on patients.
Intensity of fatigue in RA is a/w:
pain, psychological distress, morning stiffness
but not a/w:
ESR, CRP, swollen joint count
Fatigue needs its own consideration, separate to RA 'dx activity'!
ESPOIR cohort #ACR20 ABST1727 @RheumNow https://t.co/Uqu5LDvSV6
David Liew drdavidliew ( View Tweet)
Early RA window of opportunity: how hard, how early?
Commonsense reassurance from ESPOIR: to get good outcomes at 10y (DAS28≤2.6, HAQ≤0.5):
- csDMARD early
- bDMARD second line is okay, within first 1y+
(analysis weighted for subsequent Rx exposure)
#ACR20 ABST1717 @RheumNow https://t.co/kG9WYUYYef
David Liew drdavidliew ( View Tweet)
High-intensity interval training (HIIT) benefits RA, & it looks more than just exercise-FM-CV health.
Changes in T cell activity, muscle oxidative metabolism after HIIT in sedentary RA pts n=12
Looking forward to seeing more in this area
@dukemedicine #ACR20 ABST1757 @RheumNow https://t.co/5gKheEUYJ6
David Liew drdavidliew ( View Tweet)
Our RA patients are susceptible to a dangerous virus which runs rampant, but won't take the vaccine.
Why won't patients have their flu shot? @McGillMed 40% hesitant despite public funding. Multiple levels influence; if we don't address, our pts suffer!
#ACR20 ABST1740 @RheumNow https://t.co/1Yhr6I2L30
David Liew drdavidliew ( View Tweet)
Test your ACR IQ and see where you place on our leaderboard. #ACR20
https://t.co/DKSq8gKTDb https://t.co/2mgg97ejPu
Links:
Dr. John Cush RheumNow ( View Tweet)
Since MTX doesn’t work in cardiac prevention in non inflammatory pop’n (CIRT trial) should we use MTX in knee OA with inflammation? RCT n=344 w primary knee OA w swelling & pain. Rx MTX v glucosamine POSITIVE results #ACR20 abstr#1648 @RheumNow @CRASCRRheum #ACRbest https://t.co/7VptCPxKU8
Janet Pope Janetbirdope ( View Tweet)
#osteoarthritis Rx with #tanezumab - analgesic or DMOAD? RCT in knee OA of 3021 pts & only 1312 completed Rx. Tanezumab > improvement in pain v NSAIDs but NO diff in MCII and pt acceptable symptoms (PASS) over time #ACR20 #ACRbest abstr#1641 @RheumNow @CRASCRRheum https://t.co/x75ncz16uP
Janet Pope Janetbirdope ( View Tweet)
This is a great pearl from John Stone. Rapid bedside detection of nasal septal perforation in GPA. Shine light in on nostril, if you see it like this in the other then septum is perforated #ACR20 @rheumnow https://t.co/aecwAWqxOz
Richard Conway RichardPAConway ( View Tweet)
Reactive Arthritis - Chronic v. Acute: Dr. Janet Pope (@Janetbirdope)
#ACR20
https://t.co/B8jO4nodAV https://t.co/7eeS1vGWjZ
Links:
Dr. John Cush RheumNow ( View Tweet)
How comfortable do you feel managing auto inflammatory conditions?
Olga Petryna DrPetryna ( View Tweet)
Our @rheumnow RA panel discussion of ACR day 2 highlights is available to view #ACR20 https://t.co/3r0BwEW7eA
Richard Conway RichardPAConway ( View Tweet)
I just reviewed the #ACR20 talk regarding vaccination. Highly recommended/timely given data released from Pfizer today regarding the COVID-19 vaccine trial. @RheumNow
Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective - The New York Times https://t.co/Fb5ZepCBeJ
Dr. Rachel Tate uptoTate ( View Tweet)
It’s the final full day of #ACR20! Don’t miss these great posters and oral presentations👇🏼
@RheumNow https://t.co/prafBXXl6f
Mrinalini Dey DrMiniDey ( View Tweet)
Poll results are in! 86% of rheumies tuned into Dr. Fauci’s lecture live! #ACR20 @RheumNow https://t.co/YCzAfDBZgD
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Read my #ACR20 article on diet as a mechanism to control gout @rheumnow https://t.co/nEWJqt8eXx
Richard Conway RichardPAConway ( View Tweet)
Dr. Bermas presented #GRA data on 14 rheumatic Pregnant women w/ COVID-19 w/ good outcomes (4 hospitalized & no deaths) but MMWR just reported preg COVID may have worse outcomes. https://t.co/6SD6Rzbxwx https://t.co/C4QS23axfN
Links:
Dr. John Cush RheumNow ( View Tweet)
